Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1995
11/30/1995WO1995032291A2 Hepatitis g virus and molecular cloning thereof
11/30/1995WO1995032286A2 Immunogenic carcinoembryonic antigen and methods of use and production
11/30/1995WO1995032277A1 Insertional mutations in mycobacteria
11/30/1995WO1995032220A1 Cloned leptospira outer membrane protein
11/30/1995WO1995031999A1 Compositions of transactivating proteins of human immunodeficiency virus
11/30/1995WO1995031998A1 Candida albicans adhesin as a vaccine
11/30/1995WO1995031997A1 Model for testing immunogenicity of peptides
11/30/1995WO1995031996A1 Materials and methods for treatment of plaquing diseases
11/30/1995WO1995031994A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
11/30/1995WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995WO1995029662A3 Vaccine against gram-negative bacterial infections
11/30/1995WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/30/1995DE4421391C1 Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression Use of antibodies against T-cells for prolonged immunosuppression
11/30/1995CA2191202A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
11/30/1995CA2190999A1 Cloned leptospira outer membrane protein
11/30/1995CA2190972A1 Compositions of transactivating proteins of human immunodeficiency virus
11/30/1995CA2190861A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
11/30/1995CA2190860A1 Hepatitis g virus and molecular cloning thereof
11/30/1995CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis
11/29/1995EP0684311A1 Vaccines against animal parasitic nematodes
11/29/1995EP0683816A1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/29/1995EP0683793A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
11/29/1995EP0683762A1 Acylfulvene analogues as antitumor agents
11/29/1995EP0683675A1 Human monoclonal antibodies to cytomegalovirus
11/29/1995EP0683671A1 Immune system modulation using psoralens activated with visible light
11/29/1995EP0460076B1 Genetically engineered immunoglobulins
11/29/1995EP0452314B1 Adhesion receptor for laminin and its use
11/29/1995EP0440689B1 Anti-idiotypic antibody induction of antitumor response
11/29/1995EP0412116B1 Detection of neu gene expression and products
11/29/1995EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens
11/29/1995EP0344320B1 Human monoclonal antibody against candida
11/29/1995CN1112445A Oral hepatitis B antigen specific immune factor and its preparation
11/29/1995CN1112444A Treatment of infertility and enhancement of fertilization capacity in mammalian males
11/28/1995US5470997 Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
11/28/1995US5470966 Neural α-catenin
11/28/1995US5470958 Antisera against a PEB1 antigen from Campylobacter jejuni
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470953 Human β2 integrin α subunit
11/28/1995US5470835 Transfer factor and methods of use
11/28/1995US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof
11/28/1995US5470825 Basophil granule proteins
11/28/1995US5470738 Diagnostic systems for assaying platelets in a vascular fluid
11/28/1995US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
11/28/1995US5470718 Gene code polypeptides
11/28/1995US5470712 Diagnosis of Lyme disease
11/28/1995US5470702 HIV-2 transmembrane glycoprotein homodimer (gp 80)
11/28/1995US5470573 Immunogens comprising the non-lytic membrane spanning domain of bacteriophages MS2 or PhiX174
11/28/1995US5470572 Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
11/28/1995US5470560 Method for evaluating immunogenicity
11/28/1995CA2124545A1 Method of inducing cell-mediated protective immunity against hiv using low doses of immunogens
11/28/1995CA2075521C Stabilized live vaccine
11/28/1995CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto
11/28/1995CA1337641C Recombinant dna product and method
11/28/1995CA1337640C Recombinant dna product and method
11/23/1995WO1995031728A1 Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995WO1995031558A1 Process for producing hbv surface proteins
11/23/1995WO1995031555A1 Fusion glycoprotein from hcmv and hsv
11/23/1995WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
11/23/1995WO1995031549A1 Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031532A1 Papillomavirus vaccines
11/23/1995WO1995031530A1 Process for propagating avian viruses
11/23/1995WO1995031483A1 Improvements in or relating to peptide delivery
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031480A1 Heterodimer polypeptide immunogen carrier composition and method
11/23/1995WO1995031478A1 CLONING OF NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS
11/23/1995WO1995031477A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression
11/23/1995WO1995031476A1 Recombinant papilloma virus l1
11/23/1995WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031279A1 Chromatography adsorbents utilizing mercapto heterocyclic ligands
11/23/1995WO1995031216A1 Vaccine against mycobacterial infections
11/23/1995WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS)
11/23/1995WO1995031212A1 Human cd7 related compositions and methods of using the same
11/23/1995WO1995031187A1 Microparticle delivery system
11/23/1995WO1995031184A1 Bioactive molecule delivery
11/23/1995WO1995031107A1 Immunotherapeutic strategies for the treatment of cancer
11/23/1995WO1995029236A3 Lymphocyte activation antigens and antibodies thereto
11/23/1995WO1995028957A3 Methods for inducing t cell tolerance to a tissue or organ graft
11/23/1995DE4417865A1 Two component tumour therapy using necrosis inducing agent
11/23/1995CA2372569A1 Heterodimer polypeptide immunogen carrier composition and method
11/23/1995CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995CA2190529A1 Fusion glycoprotein from hcmv and hsv
11/23/1995CA2190375A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression
11/23/1995CA2190353A1 Cloning of non-iga fc binding forms of the group b streptococcal beta antigens
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2190101A1 Improvements in or relating to peptide delivery
11/23/1995CA2188421A1 Alphavirus expression vector
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0682950A1 Mucosal administration of pneumococcal antigens
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
11/22/1995EP0682705A1 Tnf-alpha muteins and a process for preparing them
1 ... 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 ... 1823